Connection

EDWARD GRAVISS to HIV Infections

This is a "connection" page, showing publications EDWARD GRAVISS has written about HIV Infections.
Connection Strength

1.858
  1. The Impact of HIV Infection on TB Disparities Among US-Born Black and White Tuberculosis Patients in the United States. J Public Health Manag Pract. 2020 Sep/Oct; 26(5):E5-E12.
    View in: PubMed
    Score: 0.309
  2. Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients. PLoS One. 2018; 13(4):e0196022.
    View in: PubMed
    Score: 0.262
  3. Yield of chest radiograph in tuberculosis screening for HIV-infected persons at a district-level HIV clinic. Int J Tuberc Lung Dis. 2016 Feb; 20(2):211-7.
    View in: PubMed
    Score: 0.225
  4. Improving the diagnosis of pulmonary tuberculosis in HIV-infected individuals in Ho Chi Minh City, Viet Nam. Int J Tuberc Lung Dis. 2011 Nov; 15(11):1528-34, i.
    View in: PubMed
    Score: 0.168
  5. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis. 2022 04; 22(4):507-518.
    View in: PubMed
    Score: 0.084
  6. Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients. Transplant Proc. 2021 Apr; 53(3):984-988.
    View in: PubMed
    Score: 0.079
  7. Clearance of HIV infection by selective elimination of host cells capable of producing HIV. Nat Commun. 2020 08 13; 11(1):4051.
    View in: PubMed
    Score: 0.077
  8. Chronic kidney disease in patients infected with human immunodeficiency virus (HIV) in an urban cohort. PLoS One. 2019; 14(4):e0215575.
    View in: PubMed
    Score: 0.070
  9. Rapid diagnosis of new and relapse tuberculosis by quantification of a circulating antigen in HIV-infected adults in the Greater Houston metropolitan area. BMC Med. 2017 11 01; 15(1):188.
    View in: PubMed
    Score: 0.063
  10. Performance of the QuantiFERON-TB gold interferon gamma release assay among HIV-infected children in Botswana. J Int Assoc Provid AIDS Care. 2015 Jan-Feb; 14(1):4-7.
    View in: PubMed
    Score: 0.051
  11. HIV infection among TB and non-TB patients in China, 2009-2012. J Infect. 2014 Apr; 68(4):399-400.
    View in: PubMed
    Score: 0.049
  12. Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centre. Clin Microbiol Infect. 2014 Mar; 20(3):263-8.
    View in: PubMed
    Score: 0.047
  13. Counting the homeless: a previously incalculable tuberculosis risk and its social determinants. Am J Public Health. 2013 May; 103(5):839-48.
    View in: PubMed
    Score: 0.046
  14. Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy. J Infect Dis. 2011 Feb 15; 203(4):496-9.
    View in: PubMed
    Score: 0.039
  15. One year survival of HIV-infected veterans with CD4 < 100 cells/mm3: data from a veteran cohort. AIDS Care. 2010 Jul; 22(7):886-94.
    View in: PubMed
    Score: 0.038
  16. Mortality associated with central nervous system tuberculosis. J Infect. 2007 Dec; 55(6):502-9.
    View in: PubMed
    Score: 0.032
  17. Foxp3+ regulatory T cells in antiretroviral-naive HIV patients. AIDS. 2006 Aug 01; 20(12):1669-71.
    View in: PubMed
    Score: 0.029
  18. Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care. 2006 May; 18(4):332-8.
    View in: PubMed
    Score: 0.029
  19. Diagnostic associations between pleural and pulmonary tuberculosis. J Infect. 2006 Dec; 53(6):377-86.
    View in: PubMed
    Score: 0.028
  20. Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active? HIV Clin Trials. 2004 May-Jun; 5(3):117-24.
    View in: PubMed
    Score: 0.025
  21. Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clin Infect Dis. 2003 Aug 01; 37(3):433-7.
    View in: PubMed
    Score: 0.024
  22. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003 Apr 01; 32(4):399-405.
    View in: PubMed
    Score: 0.023
  23. 5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas. Int J Tuberc Lung Dis. 2002 Sep; 6(9):818-23.
    View in: PubMed
    Score: 0.022
  24. An eight-year epidemiologic study of head and neck tuberculosis in Texas, USA. Tuberculosis (Edinb). 2019 05; 116S:S71-S77.
    View in: PubMed
    Score: 0.018
  25. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2016 12; 101S:S73-S77.
    View in: PubMed
    Score: 0.015
  26. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005 Mar 04; 19(4):399-406.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.